Cabozantinib (often misspelled "Cabozatinib"): Product Description, Uses, Dosing, and Safety

If you've searched for Cabozatinib, you're not alone, that spelling is common. The prescription cancer medicine is cabozantinib. This is a plain-language product description of cabozantinib for patients and caregivers who want clear, safety-first details.

Cabozantinib is an oral targeted therapy in a drug class called tyrosine kinase inhibitors (TKIs). It works by blocking signals that help tumors grow and form new blood vessels. In the US, cabozantinib is sold as two different brand products that are not interchangeable: Cabometyx (tablets) and Cometriq (capsules). They come in different forms, strengths, and dosing, so patients should never swap them without a prescriber's direction.

Because dosing and monitoring are individualized, use this as education only. Your oncology team and pharmacist should guide decisions for your diagnosis, labs, and other medicines.

What cabozantinib is, and what it's used to treat

Cabozantinib is a targeted anti-cancer medicine taken by mouth. It belongs to the "kinase inhibitor" family. Many cancers rely on kinase signals to keep growing, invade nearby tissue, and recruit blood supply. Cabozantinib aims to interrupt those signals, which may slow disease progression for certain diagnoses.

In the United States, cabozantinib has FDA-approved uses that depend on the product (Cabometyx tablets versus Cometriq capsules). For the most up-to-date indication wording and limitations, see the Cabometyx FDA prescribing information (PDF).

Common FDA-approved uses include:

• Renal cell carcinoma (RCC): advanced kidney cancer (Cabometyx), used alone in some settings or in combination with nivolumab in certain first-line RCC regimens.
• Hepatocellular carcinoma (HCC): liver cancer after prior sorafenib (Cabometyx).
• Differentiated thyroid cancer (DTC): for patients age 12 and older when radioactive iodine no longer works and after prior VEGFR-targeted therapy (Cabometyx).
• Medullary thyroid cancer (MTC): progressive, metastatic disease (Cometriq).
• Well-differentiated neuroendocrine tumors (NETs): pancreatic NET (pNET) and extra-pancreatic NET (epNET) for patients age 12 and older with previously treated, unresectable, advanced, or metastatic disease (Cabometyx).

Oncologists may also use cabozantinib "off-label" for other cancers when clinical evidence supports it. Still, off-label use is a clinician decision and depends on risks, expected benefit, and available options.

Who might not be a good fit (topics to discuss first): Cabozantinib can raise blood pressure and affect bleeding and clotting risk. It may also stress the liver. If you have uncontrolled hypertension, active bleeding, a history of serious blood clots, or significant liver disease, bring that up early so your team can plan monitoring, dose changes, or another therapy.

How it works in the body, explained in plain English

Cabozantinib blocks several "on switches" on cells, including VEGFR, MET, AXL, and RET (plus other kinases). Think of these switches like stuck buttons on a control panel. When they stay pressed, a tumor can keep getting growth signals and can build blood vessels to feed itself.

By blocking these pathways, cabozantinib can have two main effects. First, it can slow cancer cell growth and spread in tumors that rely on these signals. Second, it can reduce tumor blood supply by interfering with VEGFR-driven vessel growth. In practice, that may shrink tumors for some people or slow down progression, but responses vary and side effects often drive dose adjustments.

Cabometyx vs. Cometriq, same drug name, different products

Cabozantinib comes as Cabometyx tablets and Cometriq capsules. Even though the active drug is the same, the products are not interchangeable. They differ in dosage form, available strengths, dosing schedules, and FDA-approved uses.

As a simple guide: Cabometyx is the tablet used for kidney cancer, liver cancer after sorafenib, some thyroid cancers, and certain neuroendocrine tumors. Cometriq is the capsule used for metastatic medullary thyroid cancer. Because dosing differs a lot, mixing them up can cause underdosing or dangerous overdosing. For example, Cometriq labeling includes boxed warnings related to serious bleeding and GI perforation and fistula risk, outlined in the Cometriq FDA label (PDF).

Safety habit that helps: check the product name, strength, and dosage form on every refill. If anything looks different, call your pharmacy before taking the next dose.

Strengths, typical dosing, and how to take cabozantinib safely

Cabozantinib dosing depends on the product, diagnosis, other treatments, and side effects. Your prescriber sets the exact dose, and dose holds or reductions are common. The goal is to keep treatment effective while limiting harm.

Here's a high-level reference for typical adult dosing patterns (not a substitute for your prescription label):

For exact dosing tables and adjustment rules, your care team may reference the current Cabometyx FDA label (PDF).

How to take it:

• Take cabozantinib on an empty stomach (follow the product instructions, often "no food for at least 2 hours before and 1 hour after").
• Take it at the same time each day.
• Swallow tablets or capsules whole with water. Don't crush, split, or open them.
• If you miss a dose, follow your label and oncology team instructions. In many clinics, the advice depends on how close you are to the next scheduled dose.

Interactions matter because cabozantinib uses CYP3A4 metabolism. Some medicines can raise cabozantinib levels (more side effects), while others can lower levels (less effect). Grapefruit products and St. John's wort often come up in counseling for this reason. Before starting any new prescription, OTC product, or supplement, ask your pharmacist to screen it.

If your treatment plan includes another oral kinase inhibitor at a different time in your cancer journey, it may help to compare monitoring and interaction rules across drugs. For example, Chemistway also lists other targeted therapies like Tabrecta (capmatinib) 150 mg tablets, which has its own interaction and liver-test monitoring needs.

Food, timing, and everyday tips that reduce problems

The empty-stomach rule is annoying, but it can reduce swings in drug exposure. A simple routine helps. Many people pick a consistent "quiet hour" (for example, early morning) and build the day around it.

Hydration also helps, because diarrhea and low appetite can sneak up fast. If your stools loosen, tell the clinic early. Don't wait for days. Early care often prevents bigger dose interruptions.

Skin issues can build slowly, too. Use fragrance-free moisturizer daily, and protect hands and feet from friction and heat. For example, cushioned socks and gentle shoes can reduce pressure points. Finally, check blood pressure at home if your team recommends it. High readings often show up before you feel symptoms.

What your care team may monitor during treatment

Monitoring keeps therapy safer and helps your team adjust doses before problems escalate. The exact schedule differs by diagnosis and baseline health, but common checks include:

• Blood pressure, often at every visit and sometimes at home
• Liver blood tests (because cabozantinib can injure the liver)
• Thyroid labs when treating thyroid cancers, or if symptoms suggest changes
• Urine protein tests, because some TKIs can affect the kidneys
• Bleeding or clot symptoms, since both risks exist with anti-angiogenic drugs
• Wound healing status, because cabozantinib can slow healing after procedures

Also tell your team about planned dental work or surgery. Timing changes may be needed, but only your prescriber should direct holds and restarts.

Side effects, serious warnings, and when to get help right away

Most people on cabozantinib notice side effects, especially during the first weeks. Some are manageable with early support and dose changes. Others are medical emergencies.

Common side effects (often treatable, but report them early):

• Diarrhea
• Nausea or vomiting
• Low appetite and weight loss
• Fatigue
• High blood pressure
• Mouth sores or mouth pain
• Hand-foot skin reaction (redness, pain, peeling on palms or soles)

Serious risks (need urgent medical evaluation):

• Bleeding, which can be severe or rarely fatal
• Blood clots (deep vein thrombosis, pulmonary embolism, stroke, heart attack)
• GI perforation or fistula (a hole or abnormal connection in the gut)
• Severe high blood pressure or hypertensive crisis
• Liver injury
• Poor wound healing
• Rare brain effects, including a risk of encephalopathy reported in some liver cancer patients

If you're on cabozantinib, don't "tough it out" with red-flag symptoms. Early action can be lifesaving.

Call your doctor now or seek urgent care if you have:

• Black or tarry stools, vomiting blood, or coughing blood
• Chest pain, sudden shortness of breath, or one-sided swelling/pain in a leg
• Severe belly pain, fever with abdominal tenderness, or persistent vomiting
• Severe headache, confusion, weakness, vision changes, or fainting
• Very high home blood pressure readings based on your clinic's threshold plan

Cabozantinib can also harm an unborn baby. Avoid pregnancy during treatment, and use effective birth control for the timeframe your prescriber recommends. Don't breastfeed during treatment and for the advised period after the last dose.

Because serious safety warnings can vary by product and patient factors, your team may point you to label guidance such as the Cometriq safety warnings in the FDA label (PDF).

Common side effects people notice first, and what can help

Diarrhea and mouth soreness often show up early. Ask your clinic what to use at the first loose stool, and keep it available at home. In the meantime, bland foods, smaller meals, and steady fluids can help you keep calories in.

For mouth symptoms, a gentle rinse (your clinic may suggest salt and baking soda in water) can reduce irritation. Avoid alcohol-based mouthwashes unless your team says otherwise. When nausea hits, taking anti-nausea medicine early often works better than waiting until you feel miserable.

Hand-foot skin reaction can feel like walking on hot gravel. Moisturize often, protect pressure areas, and report pain before it limits walking or daily tasks. Dose adjustments can prevent cracks, infection, and long breaks in therapy.

Drug interactions and special precautions to keep in mind

Cabozantinib levels can change when you add or stop drugs that affect CYP3A4. Strong inhibitors (some antifungals and antibiotics) can raise cabozantinib exposure, while strong inducers (some seizure medicines) can lower it. Because the list is long, the safest move is simple: keep one updated medication list and share it with every prescriber and your pharmacy.

Also mention blood thinners, aspirin, and NSAIDs. They don't always need to be avoided, but bleeding risk may change your plan. If you have liver cancer, ask about alcohol limits because liver stress and dehydration can worsen side effects.

If your cancer has a RET-altered pathway, your oncologist may discuss other targeted options in the broader treatment picture. One example in the same "targeted therapy" category is Retevmo (selpercatinib) 40 mg capsules, which targets RET in certain cancers, but it's used for different diagnoses and has different rules.

Conclusion

Cabozantinib (often misspelled "Cabozatinib") is a targeted oral cancer medicine used for several cancers, including kidney cancer, liver cancer after sorafenib, select thyroid cancers, certain neuroendocrine tumors, and medullary thyroid cancer (with the Cometriq product). Cabometyx tablets and Cometriq capsules share the same active drug, but they're different products with different dosing and should not be swapped.

Dosing is individualized, and side effects are common. Still, many problems improve with early reporting, supportive meds, and dose adjustments. At the same time, serious warning signs like bleeding, clot symptoms, severe abdominal pain, or confusion need urgent care.

Before each refill, confirm the exact product and strength, and ask your pharmacist about interactions and monitoring. Finally, set up refill planning early so you don't miss doses during shipping or clinic schedule changes.